MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 26.03.2026
Orgenesis Anteile 2011-2026 | ORGS
Anteile Jährlich Orgenesis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.21 M | 2.9 M | 25.1 M | 24.3 M | 22.1 M | 15.9 M | 13.4 M | 9.68 M | 8.52 M | 4.65 M | 4.51 M | 4.21 M | 4.52 M | 6.71 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 25.1 M | 2.9 M | 10.8 M |
Anteile Vierteljährlich Orgenesis
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.72 M | 38.9 M | 33.2 M | 3.19 M | 3 M | 28.6 M | 26.5 M | 25.5 M | 25.4 M | 24.8 M | 24.6 M | 24.3 M | 24.3 M | 24.4 M | 24.2 M | 24.2 M | 22.1 M | 21.5 M | 17.8 M | 16.1 M | 16 M | 16 M | 15.6 M | 15.5 M | 14.4 M | 13.1 M | 15.4 M | 9.87 M | 10.3 M | 9.57 M | 9.29 M | 9.51 M | 111 M | 108 B | 103 B | 55.8 M | 55.8 M | 55.8 M | 55.7 M | 56 M | 54.9 M | 54 M | 52.1 M | 51.1 M | 51.1 M | 51.1 M | 51.1 M | 49.1 M | 49.1 M | 49.1 M | 49.1 M | 80.5 M | 80.5 M | 80.5 M | 80.5 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 108 B | 3 M | 3.87 B |
Anteile anderer Aktien in der Pharmaeinzelhändler
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
I-Mab
IMAB
|
187 M | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B |  USA |
 |
Genfit SA
GNFT
|
44.7 B | - | 2.54 % | $ 160 B |  France |
 |
Autolus Therapeutics plc
AUTL
|
266 M | $ 1.36 | -2.15 % | $ 362 M |  Britain |
 |
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M | France |
 |
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
2.41 B | $ 3.78 | 4.83 % | $ 9.09 B |  Australia |
 |
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | USA |
 |
Aytu BioScience
AYTU
|
6.28 M | $ 2.6 | -2.26 % | $ 16.3 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
10.2 M | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
14.3 M | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
2.45 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | USA |
 |
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | Germany |
 |
BioNTech SE
BNTX
|
244 M | $ 88.33 | -3.24 % | $ 27.2 B | Germany |
 |
Coherus BioSciences
CHRS
|
117 M | $ 1.62 | -2.99 % | $ 190 M | USA |
 |
Akari Therapeutics, Plc
AKTX
|
67.3 B | $ 3.5 | -1.13 % | $ 236 B | Britain |
 |
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
86.8 M | - | - | $ 28.6 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
131 M | $ 317.48 | -3.89 % | $ 41.6 B | USA |
 |
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
25.4 M | - | 10.36 % | $ 9.8 M | USA |
 |
AlloVir
ALVR
|
15.3 M | - | 4.14 % | $ 49.1 M | USA |
 |
Burford Capital Limited
BUR
|
219 M | $ 4.5 | 0.67 % | $ 729 M | Britain |
 |
Atreca
BCEL
|
38.6 M | - | -11.76 % | $ 5.79 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | USA |
 |
IDEAYA Biosciences
IDYA
|
88.5 M | $ 31.06 | -3.96 % | $ 2.75 B | USA |
 |
argenx SE
ARGX
|
51.1 M | $ 755.85 | 1.02 % | $ 25 B |  Niderland |
 |
Завод ДИОД
DIOD
|
91.5 M | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
301 M | - | - | - | Russia |
 |
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | USA |
 |
Aptorum Group Limited
APM
|
5.45 M | $ 0.89 | 0.54 % | $ 4.85 M | China |
 |
Applied Therapeutics
APLT
|
84.2 M | - | - | $ 8.42 M | USA |
 |
Aptinyx
APTX
|
67.7 M | - | -39.0 % | $ 4.57 M | USA |
 |
Teligent, Inc.
TLGT
|
5.59 M | - | -13.85 % | $ 16.1 M | USA |
 |
Cerus Corporation
CERS
|
191 M | $ 1.85 | - | $ 353 M | USA |
 |
AbbVie
ABBV
|
1.77 B | $ 204.25 | -1.15 % | $ 361 B | USA |
 |
Aquestive Therapeutics
AQST
|
107 M | $ 4.03 | -1.59 % | $ 431 M | USA |
 |
Aravive
ARAV
|
36.4 M | - | -13.39 % | $ 1.45 M | USA |
 |
Viela Bio, Inc.
VIE
|
12.3 M | - | - | $ 2.91 B | USA |
 |
AbCellera Biologics
ABCL
|
299 M | $ 3.26 | -3.98 % | $ 974 M | Canada |